Internal Medicine, Hematology & Oncology · Fresno, CA
NPI
1508024647
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
785 Medical Center Drive West, 203
Fresno, CA, 93611
Phone (559) 387-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
2,440 services
Medicare patients, 2024
691
Average age 72
Drug cost, 2024
$10.0M
3,088 prescriptions
Company payments, 2025
$103K
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haifaa Abdulhaq was code 99214 (office e&m - established), 1,457 times for 477 patients. In total Haifaa Abdulhaq billed 2,440 services in 19 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,457 | 477 | $94.86 | $138K |
| 99215 Office E&M - Established | Office | 228 | 125 | $138.92 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 197 | 83 | $93.37 | $18K |
| 99213 Office E&M - Established | Office | 119 | 94 | $62.33 | $7,417 |
| 99222 Hospital E&M - Initial | Facility | 88 | 85 | $94.78 | $8,341 |
| 99204 Office E&M - New | Office | 80 | 80 | $127.76 | $10K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 67 | 17 | $0.84 | $56.15 |
| 96372 Injection Administration | Office | 67 | 17 | $9.69 | $649 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 36 | $60.34 | $2,715 |
| 99223 Hospital E&M - Initial | Facility | 29 | 29 | $130.35 | $3,780 |
| 99205 Office E&M - New | Office | 28 | 28 | $168.91 | $4,730 |
By year: 2022 $183K for 2,043 services; 2023 $197K for 2,213 services; 2024 $229K for 2,440 services.
Medicare prescription drug claims, 2024
In 2024, the drug Haifaa Abdulhaq prescribed most often to Medicare patients was Acyclovir, with 300 prescriptions and refills. In total Haifaa Abdulhaq wrote 3,088 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 300 | 494 | 85 | $6,028 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 186 | 210 | 50 | $369 |
| Eliquis Apixaban | 114 | 151 | 31 | $84K |
| Allopurinol Generic | 107 | 167 | 36 | $777 |
| Revlimid Lenalidomide | 88 | 88 | 19 | $1.4M |
| Prednisone Generic | 86 | 93 | 36 | $282 |
| Lenalidomide Generic | 85 | 85 | 16 | $1.0M |
| Dexamethasone Generic | 83 | 94 | 35 | $771 |
| Pantoprazole Sodium Generic | 71 | 105 | 18 | $496 |
| Potassium Chloride Generic | 69 | 97 | 22 | $3,260 |
| Jakafi Ruxolitinib Phosphate | 69 | 69 | Under 11 | $1.1M |
| Prochlorperazine Maleate Generic | 58 | 58 | 31 | $484 |
| Montelukast Sodium Generic | 57 | 71 | 20 | $218 |
| Hydroxyurea Generic | 53 | 96 | 13 | $1,487 |
| Ondansetron Odt Ondansetron | 52 | 60 | 31 | $807 |
Brand drugs: 897 claims; generic drugs: 2,191 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haifaa Abdulhaq $103K ($93K in general payments such as food, travel and fees and $11K for research) from 50 companies. The largest payer was Genentech, Inc. with $40K.
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. ROG.SW | 5 | $40K |
| Genentech USA, Inc. ROG.SW | 26 | $15K |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $12K |
| F. Hoffmann-La Roche AG ROG.SW | 11 | $9,347 |
| Incyte Corporation INCY | 7 | $7,964 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $5,862 |
| Abbvie Inc. ABBV | 17 | $4,761 |
| Acrotech Biopharma Inc. | 1 | $2,633 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $2,577 |
| Astellas Pharma US Inc 4503.T | 10 | $533 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.